Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1789829
Max Phase: Preclinical
Molecular Formula: C12H19N3O2
Molecular Weight: 237.30
Molecule Type: Small molecule
Associated Items:
ID: ALA1789829
Max Phase: Preclinical
Molecular Formula: C12H19N3O2
Molecular Weight: 237.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(NCCC1CC1)OCCCc1c[nH]cn1
Standard InChI: InChI=1S/C12H19N3O2/c16-12(14-6-5-10-3-4-10)17-7-1-2-11-8-13-9-15-11/h8-10H,1-7H2,(H,13,15)(H,14,16)
Standard InChI Key: ZMYWSFVTVVHGEG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 237.30 | Molecular Weight (Monoisotopic): 237.1477 | AlogP: 1.87 | #Rotatable Bonds: 7 |
Polar Surface Area: 67.01 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.12 | CX Basic pKa: 6.57 | CX LogP: 1.17 | CX LogD: 1.12 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.71 | Np Likeness Score: -0.52 |
1. Sadek B, Shehab S, Więcek M, Subramanian D, Shafiullah M, Kieć-Kononowicz K, Adem A.. (2013) Anticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanol., 23 (17): [PMID:23891186] [10.1016/j.bmcl.2013.06.075] |
Source(1):